BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16939499)

  • 1. Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera.
    Weizer-Stern O; Adamsky K; Amariglio N; Levin C; Koren A; Breuer W; Rachmilewitz E; Breda L; Rivella S; Cabantchik ZI; Rechavi G
    Br J Haematol; 2006 Oct; 135(1):129-38. PubMed ID: 16939499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.
    Guo S; Casu C; Gardenghi S; Booten S; Aghajan M; Peralta R; Watt A; Freier S; Monia BP; Rivella S
    J Clin Invest; 2013 Apr; 123(4):1531-41. PubMed ID: 23524968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin expression in iron overload diseases is variably modulated by circulating factors.
    Ravasi G; Pelucchi S; Trombini P; Mariani R; Tomosugi N; Modignani GL; Pozzi M; Nemeth E; Ganz T; Hayashi H; Barisani D; Piperno A
    PLoS One; 2012; 7(5):e36425. PubMed ID: 22586470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.
    Breda L; Gardenghi S; Guy E; Rachmilewitz EA; Weizer-Stern O; Adamsky K; Amariglio N; Rechavi G; Giardina PJ; Grady RW; Rivella S
    Ann N Y Acad Sci; 2005; 1054():417-22. PubMed ID: 16339690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of the iron metabolism].
    Borch-Iohnsen B; Hagve TA; Hauge A; Thorstensen K
    Tidsskr Nor Laegeforen; 2009 Apr; 129(9):858-62. PubMed ID: 19415084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression.
    Camberlein E; Zanninelli G; Détivaud L; Lizzi AR; Sorrentino F; Vacquer S; Troadec MB; Angelucci E; Abgueguen E; Loréal O; Cianciulli P; Lai ME; Brissot P
    Haematologica; 2008 Jan; 93(1):111-5. PubMed ID: 18166793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.
    Nicolas G; Viatte L; Lou DQ; Bennoun M; Beaumont C; Kahn A; Andrews NC; Vaulont S
    Nat Genet; 2003 May; 34(1):97-101. PubMed ID: 12704388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
    Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
    Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron.
    Gehrke SG; Kulaksiz H; Herrmann T; Riedel HD; Bents K; Veltkamp C; Stremmel W
    Blood; 2003 Jul; 102(1):371-6. PubMed ID: 12637325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.
    Kattamis A; Papassotiriou I; Palaiologou D; Apostolakou F; Galani A; Ladis V; Sakellaropoulos N; Papanikolaou G
    Haematologica; 2006 Jun; 91(6):809-12. PubMed ID: 16769583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
    Vadolas J; Ng GZ; Kysenius K; Crouch PJ; Dames S; Eisermann M; Nualkaew T; Vilcassim S; Schaeper U; Grigoriadis G
    Br J Haematol; 2021 Jul; 194(1):200-210. PubMed ID: 33942901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.
    Lin L; Valore EV; Nemeth E; Goodnough JB; Gabayan V; Ganz T
    Blood; 2007 Sep; 110(6):2182-9. PubMed ID: 17540841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin independent iron recycling in a mouse model of β-thalassaemia intermedia.
    Frazer DM; Wilkins SJ; Mirciov CS; Dunn LA; Anderson GJ
    Br J Haematol; 2016 Oct; 175(2):308-317. PubMed ID: 27410488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
    Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
    Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
    Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
    Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.